Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,460 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

39,460 Papers indexed
1,440 Papers AI scored
39,460 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39460 results
C
Complication Differences Across Elective, Minimally Invasive, Outpatient Hysterectomy and Myomectomy.
PMID 40154572 Published: 2025-03-26 Ingested: 2026-08-02 12:03 AM Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 70.0; recency: 90.0; abstract quality: 85.0.

C
Demographic Differences in Mortality in the District of Columbia.
PMID 40152862 Published: 2025-03-03 Ingested: 2026-08-02 12:04 AM JAMA network open
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Vascularized iliac crest free flap in maxillofacial reconstruction: Pearls and pitfalls from 437 clinical application.
PMID 40120645 Published: 2025-03-20 Ingested: 2026-08-02 12:03 AM Journal of stomatology, oral and maxillofacial surgery
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 70.0; recency: 90.0; abstract quality: 85.0.

C
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Prevalence and impact of fertility preservation among young women with breast cancer.
PMID 40038347 Published: 2025-03-04 Ingested: 2026-08-02 12:04 AM Scientific reports
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 70.0; recency: 90.0; abstract quality: 85.0.

C
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 40.0; recency: 90.0; abstract quality: 100.0.

C
Leveraging Explainable AI for Early Risk Prediction and Type Classification for Leukemia: Insights Using Clinical Data From Pakistan.
PMID 40031230 Published: 2025-07-01 Ingested: 2026-08-02 12:04 AM IEEE journal of biomedical and health informatics
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 70.0; recency: 90.0; abstract quality: 85.0.

C
Human Papillomavirus Vaccination for Boys: Insights into Knowledge, Acceptance, and Willingness to Pay among Parents in Yogyakarta, Indonesia.
PMID 40022706 Published: 2025-02-01 Ingested: 2026-08-02 12:03 AM Asian Pacific journal of cancer prevention : APJCP
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
High APEX1 Expression Facilitates Osteosarcoma Cell Proliferation.
PMID 40022689 Published: 2025-02-01 Ingested: 2026-08-02 12:03 AM Asian Pacific journal of cancer prevention : APJCP
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 65.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Applied theory of planned behavior to explore associated factor of physical activity level among Chinese childhood cancer survivors.
PMID 40011414 Published: 2025-02-26 Ingested: 2026-08-02 12:03 AM Journal of cancer survivorship : research and practice
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

Previous
Page 1826 of 3289
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic